Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Jul 28;130(2):253-260.
doi: 10.1017/S0007114522002859. Epub 2022 Sep 23.

Cognitive effects of guarana supplementation with maximal intensity cycling

Tom Gurney  1   2 , Naomi Bradley  1 , Dionisio Izquierdo  1 , Flaminia Ronca  1
Affiliations
Randomized Controlled Trial

Cognitive effects of guarana supplementation with maximal intensity cycling

Tom Gurney et al. Br J Nutr. .

Abstract

The aim of this study was to investigate the effects of guarana supplementation on cognitive performance before and after a bout of maximal intensity cycling and to compare this to an equivalent caffeine dose. Twenty-five participants completed the randomised double-blind crossover trial by performing cognitive tests with one of three supplements, on three different days: guarana (125 mg/kg), caffeine (5 mg/kg) or placebo (65 mg/kg protein powder). After 30 min of rest, participants performed simple (SRT) and choice reaction time (CRT) tests, an immediate word recall test and Bond-Lader mood scale. This was followed by a cycling V̇O2max test, and cognitive tests were then immediately repeated. Guarana supplementation decreased CRT before exercise (407 (sd 45) ms) in comparison with placebo (421 (sd 46) ms, P = 0·030) but not caffeine (417 (sd 42) ms). SRT after exercise decreased following guarana supplementation (306 (sd 28) ms) in comparison with placebo (323 (sd 32) ms, P = 0·003) but not caffeine (315 (sd 32) ms). Intra-individual variability on CRT significantly improved from before (111·4 (sd 60·5) ms) to after exercise (81·85 (sd 43·1) ms) following guarana supplementation, and no differences were observed for caffeine and placebo (P > 0·05). Alertness scores significantly improved following guarana supplementation (63·3 (sd 13·8)) in comparison with placebo (57·4 (sd 13·4), P = 0·014) but not caffeine (61·2 (sd 12·8)). There were no changes to V̇O2max, immediate word recall or any other Bond-Lader mood scales. Guarana supplementation appears to impact several parameters of cognition. These results support the use of guarana supplementation to possibly maintain speed of attention immediately following a maximal intensity exercise test (V̇O2max).

Keywords: Alertness; Cognitive performance; Nutrition; Paullinia cupana; Reaction time.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Mean and individual simple reaction time (SRT) before and after exercise. *Signifies a significant difference (P ≤ 0·05) between supplements and SRT.
Fig. 2.
Fig. 2.
Mean and individual choice reaction time (CRT) before and after exercise. *Signifies a significant difference (P ≤ 0·05) between supplements and CRT.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Schimpl FC, da Silva JF, de Carvalho Gonçalves JF, et al. (2013) Guarana: revisiting a highly caffeinated plant from the Amazon. J Ethnopharmacol 150, 14–31. - PubMed
    1. Marques LLM, Ferreira EDF, de Paula MN, et al. (2019) Paullinia cupana: a multipurpose plant-a review. Rev Bras Farmacognosia 29, 77–110.
    1. McLellan TM, Caldwell JA & Lieberman HR (2016) A review of caffeine’s effects on cognitive, physical and occupational performance. Neurosci Biobehav Rev 71, 294–312. - PubMed
    1. Maughan RJ, Burke LM, Dvorak J, et al. (2018) IOC consensus statement: dietary supplements and the high-performance athlete. Int J Sport Nutr Exerc Metab 28, 104–125. - PubMed
    1. Grzegorzewski J, Bartsch F, Köller A, et al. (2021) Pharmacokinetics of caffeine: a systematic analysis of reported data for application in metabolic phenotyping and liver function testing. Front Pharmacol 12, 752826. - PMC - PubMed

Publication types